CorNeat EverPatch for Glaucoma
This trial will test how safe and effective a new device is at hiding artificial ocular implants.
- Tissue Necrosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are people able to currently enroll in this research?
"According to the information provided by clinicaltrials.gov, this trial is not in a recruitment phase at present. The post was first made on August 1st 2022 and its most recent revision happened on July 19th 2022. Albeit inactive, there are 206 other trials actively enrolling patients right now."
Is the protocol for this experiment including individuals who are beyond middle-age?
"This clinical trial stipulates that patients must be aged between 18 and 80 years old. In addition, there are 23 studies for minors under the age of 18 and 191 opportunities available to those who exceed 65 years of seniority."
What type of individual would be the best candidate for this experiment?
"To be eligible for this study, subjects must have a glaucoma diagnosis and fall between the ages of 18 to 80. Sixty participants are needed in total."